Redemptive Therapy Institute

Research

We are currently partnering with multiple institutions to run statistical analyses on existing datasets that contain aggregate data on psychedelic use.

We plan to fund and conduct a randomized controlled clinical trial:

• Please see link for proposed clinical trial – Click here
• We will need to raise approximately $500,000 USD to carry out this clinical trial
• After we raise all necessary funds, we will begin recruitment for the clinical trial

Advocacy

We support rescheduling psychedelic drugs out of Schedule 1 so as to allow for more research on psychedelics.

Treatment

In addition to carrying out clinical research and advocating for rescheduling, our goal is to provide evidence-based, trauma-informed psychedelic-assisted therapy, regardless of socioeconomic status.

We will begin offering therapy after MDMA and/or psilocybin become FDA-approved.